SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-23-067324
Filing Date
2023-12-01
Accepted
2023-12-01 16:05:12
Documents
1
Period of Report
2023-11-30

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3675
  Complete submission text file 0000950170-23-067324.txt   5118
Mailing Address 200 SMITH STREET WALTHAM MA 02451
Business Address 200 SMITH STREET WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Issuer) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DECIPHERA PHARMACEUTICALS, INC. 200 SMITH STREET WALTHAM MA 02451
Business Address
Martin Daniel C. (Reporting) CIK: 0001752827 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38219 | Film No.: 231459499